NCT04912102View on ClinicalTrials.gov

HFNO Versus Nasal CPAP in Obese Patients Undergoing Deep Sedation for ERCP

NANot yet recruitingINTERVENTIONAL

Enrollment

270

Participants

Timeline

Start Date

October 30, 2021

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2025

Conditions

Obese

Interventions

DEVICE

high flow nasal oxygen device (HFNO)

it is a novel technique by which heated humidified oxygen is supplied via nasal prongs at flow rates ranging from 40 to 70 L/minute. The Fio2 ranges from 0.21 to 1.0.

All Listed Sponsors

lead

Assiut University

OTHER

NCT04912102 - HFNO Versus Nasal CPAP in Obese Patients Undergoing Deep Sedation for ERCP | Biotech Hunter | Biotech Hunter